| 0.84 0.04 (5%) | 04-23 15:40 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 1.46 | 1-year : | 1.7 |
| Resists | First : | 1.25 | Second : | 1.46 |
| Pivot price | 0.76  |
|||
| Supports | First : | 0.68 | Second : | 0.33 |
| MAs | MA(5) : | 0.76 |
MA(20) : | 0.83 |
| MA(100) : | 1.04 |
MA(250) : | 1.56 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 50.1 |
D(3) : | 46.3 |
| RSI | RSI(14): 48.7 |
|||
| 52-week | High : | 2.9 | Low : | 0.33 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PETV ] has closed below upper band by 39.2%. Bollinger Bands are 83.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.84 - 0.84 | 0.84 - 0.85 |
| Low: | 0.74 - 0.75 | 0.75 - 0.75 |
| Close: | 0.83 - 0.84 | 0.84 - 0.85 |
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Mon, 08 Apr 2024
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN - GlobeNewswire
Mon, 11 Mar 2024
PetVivo Ends ATM Sales Agreement, Raises $959k - TipRanks.com - TipRanks
Mon, 11 Mar 2024
Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer - GlobeNewswire
Tue, 05 Mar 2024
PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV - GlobeNewswire
Fri, 01 Mar 2024
New to The Street Announces its Line-up, Four Corporate Interviews Airings on The FOX Business Network, Monday ... - Yahoo Finance
Thu, 29 Feb 2024
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 17 (M) |
| Held by Insiders | 1.165e+007 (%) |
| Held by Institutions | 38.4 (%) |
| Shares Short | 128 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -1.018e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -358.1 % |
| Return on Assets (ttm) | -207.8 % |
| Return on Equity (ttm) | -1 % |
| Qtrly Rev. Growth | 1.05e+006 % |
| Gross Profit (p.s.) | 8 |
| Sales Per Share | 126.88 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | -0.9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 29.39 |
| Dividend | 0 |
| Forward Dividend | 129100 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|